Cucurbitacin D's Effect on Cancer Cells
Author Information
Author(s): Adorisio Sabrina, Fierabracci Alessandra, Cham Ba Thi, Hoang Vu Dinh, Thuy Linh Nguyen Thi, Nhung Le Thi Hong, Martelli Maria Paola, Ayroldi Emira, Ronchetti Simona, Rosati Lucrezia, Di Giacomo Silvia, Thuy Trinh Thi, Delfino Domenico Vittorio, Barbalho Sandra, Araujo Adriano, Alonso-Castro Angel Josabad
Primary Institution: University of Perugia
Hypothesis
Does cucurbitacin D modulate ZNF217 expression in acute myeloid leukemia cells?
Conclusion
Cucurbitacin D significantly reduces ZNF217 expression in nucleophosmin-mutated acute myeloid leukemia cells, suggesting its potential as a treatment.
Supporting Evidence
- Cucurbitacin D reduced the number of acute myeloid leukemia cells.
- It increased apoptosis and blocked cell cycle progression.
- ZNF217 expression was significantly decreased in nucleophosmin-mutated cells.
- The effects were not observed in other hematological cancer cell lines.
Takeaway
Cucurbitacin D can help fight a type of blood cancer by making cancer cells die and stopping them from growing.
Methodology
Cucurbitacins were isolated from Elaeocarpus hainanensis and tested on acute myeloid leukemia cell lines for effects on cell viability, apoptosis, and ZNF217 expression.
Limitations
The study primarily focused on one type of leukemia and further research is needed to explore the mechanisms in depth.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website